Ashcroft, G. W., and Sharman, D. F. (1960). 5-Hydroxyindoles in human cerebrospinal fluids. Nature, 186, 1050–1051.
Ashcroft, G. W., and Sharman, D. F. (1962). Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus. British Journal of Pharmacology, 19, 153–160.
Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Sharman, D. F., MacDougall, E. J., Stanton, J. B., and Binns, J. K. (1966). 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet, 2, 1049–1052.
Ashcroft, G. W., Blackburn, I. M., Eccleston, D., Glen, A. I. M., Hartley, W., Kinloch, N. E., Lonergan, M., Murray, L. G., and Pullar, I. A. (1973). Changes on recovery in the concentrations of the biogenic amines in the c.s.f. of patients with affective illness. Psychological Medicine, 3, 319–325.
Bowers, M. B. Jr., and Gerbode, A. F. (1968). Relationship of monoamine metabolites in human cerebrospinal fluid to age. Nature, 219, 1256–1257.
Bulat, M., and Zivković, B. (1971). Origin of 5-hydroxyindoleacetic acid in the spinal fluid. Science, 173, 738–740.
Dencker, S. J., Malm, U., Roos, B.-E., and Werdinius, B. (1966). Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. Journal of Neurochemistry, 13, 1545–1548.
Eccleston, D., Ashcroft, G. W., Crawford, T. B. B., Stanton, J. B., Wood, D., and McTurk, P. H. (1970). Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man. Journal of Neurology, Neurosurgery and Psychiatry, 33, 269–272.
Eccleston, D., Ashcroft, G. W., Moir, A. T. B., Parker-Rhodes, A., Lutz, W., and O'Mahoney, D. P. (1968). A comparison of 5-hydroxyindoles in various regions of dog brain and cerebrospinal fluid. Journal of Neurochemistry, 15, 947–957.
Guldberg, H. C., and Yates, C. M. (1968). Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid. British Journal of Pharmacology and Chemotherapy, 33, 457–471.
Guroff, G., and Udenfriend, S. (1962). Studies on aromatic amino acid uptake by rat brain in vivo. Journal of Biological Chemistry 237, 803–806.
Hess, S. M., and Udenfriend, S. (1959). A fluorometric procedure for the measurement of tryptamine in tissues. Journal of Pharmacology and Experimental Therapeutics, 127, 175–177.
Knott, P. J., and Curzon, G. (1972). Free tryptophan in plasma and brain tryptophan metabolism. Nature, 239, 452–453.
McMenamy, R. H., Lund, C. C., and Oncley, J. L. (1957). Unbound amino acid concentrations in human blood plasmas. Journal of Clinical Investigation, 36, 1672–1679.
Moir, A. T. B., and Eccleston, D. (1968). The effects of precursor loading in the cerebral metabolism of 5-hydroxy-indoles. Journal of Neurochemistry, 15, 1093–1108.
Praag, H. M. van., Korf, J., and Puite, J. (1970). 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probeneeid. Nature 225, 1259 1260.
Sheard, M. H., and Aghajanian, G. K. (1968). Stimulation of the midbrain raphe: effect on senotonin metabolism. Journal of Pharmacology and Experimental Therapy, 163, 425–430.
Shields, P. J., and Eccleston, D. (1972). Effects of electrical stimulation of rat midbrain on 5-hydroxytryptamine synthesis as determined by a sensitive radiosotope method. Journal of Neurochemislry, 19, 265–272.